Amlodipine, felodipine, and isradipine in the treatment of Chinese patients with mild-to-moderate hypertension

Clinical Therapeutics

Volumn 20, Issue 6, 1998, Pages 1159-1169

  Cheung, Bernard M Y ^a,b   Lau, Chu Pak ^a   Wu, Bi Zhen ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Amlodipine; Calcium channel blockers; Dihydropyridines; Felodipine; Hypertension; Isradipine

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; FELODIPINE; ISRADIPINE;

ADULT; CHINESE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; ESSENTIAL HYPERTENSION; FEMALE; FLUSHING; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; VERTIGO;

EID: 0032418198     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(98)80111-2     Document Type: Conference Paper

References (29)

1. 1. Hansson L, Zanchetti A, Carrithers SG, et al, for the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998;351:1755-1762.
2. 2. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-183.
3. 3. Sever P, Beevers G, Bulpitt C, et al. Management guidelines in essential hypertension: Report of the second working party of the British Hypertension Society. BMJ. 1993;306:983-987.
4. 4. Liebson PR. Clinical studies of drug reversal of hypertensive left ventricular hypertrophy. Am J Hypertens. 1990;3:512-527.
5. 5. Chan JC, Cockram CS, Nicholls MG, et al. Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes mellitus associated with hypertension: One year analysis. BMJ. 1992;305:981-985.
6. 6. De Keyser P, Bouve J, Clement D, et al. Isradipine in essential hypertension: The Belgian General Practitioner study. Am J Med. 1989;86(Suppl 4A):103-109.
7. 7. Welzel D, Burger KJ, Weidinger G. Calcium antagonists as first-line antihypertensive agents: A placebo-controlled trial of isradipine and nifedipine. J Cardiovasc Pharmacol. 1990;15(Suppl 1):S70-S74.
8. 8. Rocha-Goncalves F, Mariano-Pego G, Viegas J, et al. First clinical experience with isradipine in the treatment of hypertension in Portugal. J Cardiovasc Pharmacol. 1991;18(Suppl 3):S4-S6.
9. 9. Holmes D, Moullet C. Clinical evaluation of once-daily administration of a modified-release formulation of isradipine and twice-daily administration of the standard formulation. J Cardiovasc Pharmacol. 1992;19(Suppl 3):S61-S65.
10. 10. Hosie J, Bremner AD, Fell PH, et al. Comparison of early side effects with amlodipine and nifedipine retard in hypertension. Cardiology. 1992;80(Suppl 1):54-59.
11. 11. Waeber B, Borges ET, Christeler P, et al. Amlodipine compared to nitrendipine in hypertensive patients: The effects on toleration in relationship to the onset of action. Cardiology. 1992;80(Suppl 1):46-53.
12. 12. Lorimer AR, Smedsrud T, Walker P, Tyler HM. A comparison of amlodipine, verapamil and placebo in the treatment of mild-to-moderate hypertension. J Hum Hvpertens. 1989;3:191-196.
13. 13. Varrone J, and the Investigators of Study AML-NY-86-002. A study of the efficacy and safety of amlodipine for the treatment of hypertension in general practice. Postgrad Med J. 1991;67(Suppl 5):S28-S31.
14. 14. Cooperative Study Group. Felodipine, a new calcium antagonist as monotherapy in mild or moderate hypertension. Drugs. 1987;34(Suppl 3):139-148.
15. 15. Harrington K, Fitzgerald P, O'Donnell P, et al. Short and long term treatment of essential hypertension with felodipine as monotherapy. Drugs. 1987;34(Suppl 3): 178-185.
16. 16. Nelson EB, Pool JL, Taylor AA. Antihypertensive efficacy of isradipine in humans: A new dihydropyridine calcium channel antagonist. Clin Pharmacol Ther. 1986;40:694-697.
17. 17. Isradipine in Hypertension Study Group. A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension. Am J Med. 1989;86(Suppl 4A):94-97.
18. 18. Man in't Velt AJ. Calcium antagonists in hypertension. Am J Med. 1989;86(Suppl 4A):6-14.
19. 19. Saltiel E, Ellrodt AG, Monk JP, et al. Felodipine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension. Drugs. 1988;35:387-428.
20. 20. Simonsen K, Sundstedt C-D. Dose-response relationship and incidence of adverse drug reactions with isradipine in patients with essential hypertension. Am J Med. 1989;86(Suppl 4A):91-93.
21. 21. The Italian-Belgian Isradipine Study Group. Multicenter evaluation of the safely and efficacy of isradipine in patients with essential hypertension. Am J Med. 1989;86(Suppl 4A):94-97.
22. 22. Culter SA, Hammond JJ, for the Physician's Study Group. A multicenter comparison of isradipine and felodipine in the treatment of mild-to-moderate hypertension. Am J Hypertens. 1993;6(Suppl):44S-48S.
23. 23. Hermans L, Bogaert M, Degaute J, et al. Tolerability of isradipine in the treatment of mild-to-moderate hypertension in general practice: A large-scale surveillance study. J Cardiovasc Pharmacol. 1992;19 (Suppl 3):S38-S45.
24. 24. Lau CP, Cheung BMY. Relative efficacy and tolerability of lacidipine and amlodipine in patients with mild-to-moderate hypertension: A randomised double-blind study. J Cardiovasc Pharmacol. 1996; 28:328-331.
25. 25. Weir MR, Hall PS, Behrens MT, Flack JM. Salt and blood pressure responses to calcium antagonism in hypertensive patients. Hypertension. 1997;30:422-427.
26. 26. Bainbridge AD, Herlihy O, Meredith PA, Elliott HL. A comparative assessment of amlodipine and felodipine ER: Pharmacokinetic and pharmacodynamic indices. Eur J Clin Pharmacol. 1993;45:425-430.
27. 27. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 1995;274:620-625.
28. 28. Gong L, Zhang W, Zhu Y, et al. Shanghai Trial of Nifedipine in the Elderly (STONE). J Hypertens. 1996;14:1237-1245.
29. 29. Staessen JA, Fagard R, Thijs L, et al, for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997;350:757-764.